A ligand binding assay for E-selectin
Related Experiment Video
Updated: Oct 17, 2026

Analysis of Physiologic E-Selectin-Mediated Leukocyte Rolling on Microvascular Endothelium
Published on: February 10, 2009
M Anostario1, S H Li, K S Huang
1Department of Inflammation/Autoimmuine Disease, Hoffmann-La Roche, Inc., Nutley, New Jersey 07110.
Abstract:
We describe here a cell-free ligand binding assay for E-selectin. The assay involves immobilizing soluble E-selection onto microtiter plates and incubating with 125I-labeled carcinoembryonic antigen (CEA) which carries the tetrasaccharide sialyl Lewis x (sLex). The bound CEA is eluted by ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N',-tetraacetic acid and monitored by radioactivity. The binding is abolished by preincubation of either CEA with an anti-sLex antibody or E-selectin with a neutralizing anti-E-selectin antibody, indicating that this is an E-selectin/sLex-specific interaction. The binding is Ca2+ and pH dependent (the optimal pH at 7.0) and also requires sialic acid. Removal of sialic acid from CEA by neuraminidase digestion abrogates the binding. When the protein but not carbohydrate constituent of CEA was denatured by reduction and alkylation, the binding was partially eliminated, indicating that the interaction may also be dependent on either protein conformation or carbohydrate orientation. The assay is simple, sensitive, and comparable to other methods as indicated by an IC50 of 1 mM for sLex. Thus, the assay should be useful for screening antagonists and studying E-selectin structure/function.
More Related Videos
08:40An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions
Published on: March 14, 2016
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018